| 000 | 01355 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515113858.0 | ||
| 264 | 0 | _c20080624 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2008.01.046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKandaswamy, R | |
| 245 | 0 | 0 |
_aCan we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation? _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cMar 2008 |
||
| 300 |
_a516-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPancreas Transplantation _ximmunology |
| 650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 700 | 1 | _aDunn, T | |
| 700 | 1 | _aHumar, A | |
| 700 | 1 | _aSutherland, D E R | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 40 _gno. 2 _gp. 516-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2008.01.046 _zAvailable from publisher's website |
| 999 |
_c17873999 _d17873999 |
||